BAMOMAB will cease delivery of antibodies/reagents by January 31, 2014.

Please place your last orders until December 31, 2013.


BAMOMAB provides high-quality reagents for immunological research to the scientific community.

Our products include novel monoclonal antibodies specific for NK cell receptors and NK cell receptor ligands developed at the University of Tübingen. Read more about our products and order information.